Beurs gesloten -
Nasdaq
22:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
23,45
USD
|
+0,17%
|
|
+3,40%
|
+29,70%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
168,8
|
382,4
|
1.790
|
878,8
|
767
|
1.001
|
-
|
-
|
Bedrijfswaarde
1 |
76,71
|
260,9
|
1.381
|
570
|
280,6
|
689,6
|
772,2
|
901
|
K/w-verhouding
|
-3,4
x
|
-6,75
x
|
-22,8
x
|
-7,79
x
|
-3,56
x
|
-4,42
x
|
-4,2
x
|
-4,25
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
12,2
x
|
36,8
x
|
153
x
|
60,8
x
|
28,4
x
|
35,8
x
|
36
x
|
20,8
x
|
Bedrijfswaarde/omzet
|
5,56
x
|
25,1
x
|
118
x
|
39,4
x
|
10,4
x
|
24,7
x
|
27,8
x
|
18,8
x
|
Bedrijfswaarde/EBITDA
|
-3,03
x
|
-5,15
x
|
-21,5
x
|
-5,05
x
|
-1,53
x
|
-3,32
x
|
-3,12
x
|
-3,37
x
|
Bedrijfswaarde/FCF
|
-2,54
x
|
-13,7
x
|
-82,1
x
|
-5,42
x
|
-4,42
x
|
-3,27
x
|
-3,03
x
|
-3,42
x
|
FCF Yield
|
-39,3%
|
-7,28%
|
-1,22%
|
-18,4%
|
-22,6%
|
-30,6%
|
-33%
|
-29,2%
|
Price to Book
|
-
|
-
|
4,41
x
|
3,24
x
|
2,07
x
|
3,75
x
|
19,1
x
|
-
|
Aantal aandelen (in duizenden)
|
17.903
|
21.305
|
29.400
|
29.689
|
42.422
|
42.673
|
-
|
-
|
Referentieprijs
2 |
9,430
|
17,95
|
60,87
|
29,60
|
18,08
|
23,45
|
23,45
|
23,45
|
Datum van publicatie
|
10/03/20
|
11/03/21
|
1/03/22
|
28/02/23
|
20/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
13,8
|
10,39
|
11,7
|
14,46
|
26,98
|
27,96
|
27,8
|
48,05
|
EBITDA
1 |
-25,34
|
-50,68
|
-64,21
|
-113
|
-183,4
|
-207,4
|
-247,8
|
-267,4
|
Bedrijfsresultaat (EBIT)
1 |
-26,3
|
-51,96
|
-65,62
|
-116,7
|
-189,9
|
-235,3
|
-271,6
|
-292,5
|
Operationele Marge
|
-190,56%
|
-500,1%
|
-560,98%
|
-806,56%
|
-704,13%
|
-841,48%
|
-976,74%
|
-608,79%
|
Resultaat voor belastingen (EBT)
1 |
-30,86
|
-51,73
|
-68,48
|
-114,2
|
-179,2
|
-232,9
|
-269,7
|
-289,9
|
Nettowinst (verlies)
1 |
-30,61
|
-51,01
|
-66,82
|
-112,7
|
-180,7
|
-228,2
|
-265,4
|
-289,5
|
Nettomarge
|
-221,78%
|
-490,95%
|
-571,25%
|
-779,35%
|
-669,72%
|
-816,14%
|
-954,48%
|
-602,6%
|
WPA
2 |
-2,770
|
-2,660
|
-2,670
|
-3,800
|
-5,080
|
-5,301
|
-5,586
|
-5,512
|
Free Cash Flow
1 |
-30,17
|
-18,99
|
-16,82
|
-105,1
|
-63,56
|
-210,9
|
-254,8
|
-263,2
|
FCF-marge
|
-218,59%
|
-182,76%
|
-143,83%
|
-726,67%
|
-235,61%
|
-754,43%
|
-916,27%
|
-547,77%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/03/20
|
11/03/21
|
1/03/22
|
28/02/23
|
20/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
4,333
|
3,771
|
3,86
|
4,378
|
3,04
|
3,185
|
4,896
|
11,4
|
5,352
|
5,331
|
6,033
|
6,292
|
6,337
|
7,435
|
5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-14,29
|
-18,02
|
-27,38
|
-27,3
|
-29,76
|
-32,21
|
-41,8
|
-43,11
|
-50,8
|
-54,24
|
-55,04
|
-58,14
|
-60,55
|
-60,76
|
-75,5
|
Operationele Marge
|
-329,89%
|
-477,94%
|
-709,4%
|
-623,57%
|
-978,91%
|
-1.011,33%
|
-853,82%
|
-378,27%
|
-949,12%
|
-1.017,35%
|
-912,22%
|
-924,03%
|
-955,37%
|
-817,2%
|
-1.510%
|
Resultaat voor belastingen (EBT)
1 |
-15,09
|
-18,78
|
-27,98
|
-27,28
|
-28,58
|
-30,4
|
-39,68
|
-43,12
|
-47,63
|
-48,78
|
-55,13
|
-58,46
|
-60,43
|
-61,42
|
-71,3
|
Nettowinst (verlies)
1 |
-14,68
|
-18,04
|
-27,56
|
-26,83
|
-28,35
|
-29,98
|
-39,06
|
-42,6
|
-49,9
|
-49,1
|
-53,99
|
-57,36
|
-60,08
|
-60,53
|
-71,3
|
Nettomarge
|
-338,75%
|
-478,31%
|
-714,09%
|
-612,79%
|
-932,47%
|
-941,22%
|
-797,88%
|
-373,81%
|
-932,32%
|
-921,01%
|
-894,9%
|
-911,74%
|
-947,99%
|
-814,08%
|
-1.426%
|
WPA
2 |
-0,5900
|
-0,6300
|
-0,9300
|
-0,9000
|
-0,9600
|
-1,010
|
-1,300
|
-1,410
|
-1,260
|
-1,160
|
-1,282
|
-1,349
|
-1,385
|
-1,373
|
-1,440
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
4/11/21
|
1/03/22
|
5/05/22
|
4/08/22
|
3/11/22
|
28/02/23
|
4/05/23
|
3/08/23
|
2/11/23
|
20/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
92,1
|
121
|
409
|
309
|
486
|
311
|
229
|
99,6
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-30,2
|
-19
|
-16,8
|
-105
|
-63,6
|
-211
|
-255
|
-263
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-30,3%
|
-36,5%
|
-56,3%
|
-66,2%
|
-157%
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
-
|
-
|
13,80
|
9,130
|
8,740
|
6,260
|
1,230
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
1,56
|
1,2
|
2,03
|
19
|
2,93
|
2,65
|
2,58
|
3,68
|
Capex/omzet
|
11,27%
|
11,55%
|
17,35%
|
131,28%
|
10,86%
|
9,48%
|
9,26%
|
7,65%
|
Datum van publicatie
|
10/03/20
|
11/03/21
|
1/03/22
|
28/02/23
|
20/02/24
|
-
|
-
|
-
|
Laatste slotkoers
23,45
USD Gemiddelde koersdoel
43,99
USD Spread / Gemiddelde doel +87,58% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +29,70% | 999 mln. | | -3,46% | 102 mld. | | +1,41% | 96,29 mld. | | +2,13% | 22,18 mld. | | -15,84% | 21,2 mld. | | -9,21% | 18,31 mld. | | -39,98% | 17,38 mld. | | -14,65% | 16,36 mld. | | +4,39% | 13,97 mld. | | +31,35% | 12,17 mld. |
Biotherapeutische geneesmiddelen
|